Cathy Conry-Cantilena is a Transfusion Medicine research physician emerita at the National Institutes of Health.
Education
editConry-Cantilena received her medical degree from Dartmouth Medical School.
Career
editConry-Cantilena has served as director of the Transfusion Medicine Fellowship program at the NIH, and as medical director for the Greater Chesapeake and Potomac Region of the American Red Cross.[1]
In 2021, Conry-Cantilena was awarded the Richard J. Davey Lectureship for her contributions to research, clinical practice and education, at the 40th Annual Immunohematology and Blood Transfusion Symposium held jointly by her department and the American Red Cross. Her lecture summarized highlights of her 26 years as a director in the Department of Transfusion Medicine.[2] Her research has covered the hepatitis C virus (HCV), the use of granulocyte transfusions, red cell support for sickle cell anemia patients, convalescent plasma for COVID-19 treatment, and graft vs. host disease.
Health challenges
editIn 2000, a routine chest x-ray led to her diagnosis of lymphangioleiomyomatosis (LAM), a rare, progressive, incurable cystic lung disease. By 2005, she was oxygen-dependent and in need of a lung transplant. She underwent a successful double-lung transplant in 2006 and went on to continue working at her two medical-director positions and raising her four children, even returning to skiing.[1]
References
edit- ^ a b Hartman Cohen, Paula (Spring 2007). "The Other Side of the Stethoscope". Dartmouth Medicine Magazine. Retrieved 29 August 2024.
- ^ "Department of Transfusion Medicine leads two days of blood science symposia". NIH Clinical Center News. Fall 2021. Retrieved 29 August 2024.
External links
edit- Official website of NIH Clinical Center
- Researchgate profile
- Contributions from Researchgate